The Serum Institute of India which had paused the trials of Oxford-AstraZeneca vaccine has been allowed to restart them. The Drugs Controller General of India (DCGI) has allowed the Serum Institute of India (SII) to continue testing the Oxford-AstraZeneca vaccine after it had been suspended on September 11, following an unexplained neurological illness in one ...

India will be using a digital infrastructure for the dissemination and inventory management of the novel Covid-19 virus vaccine once it becomes available. It is also devising a fool proof method of procurement including both indigenous and international. This will also include guiding principles to prioritize focus groups. The national expert group on vaccine administration ...

Corona pandemic is one of the worst threat to humanity in modern times and it is very difficult to defend the spread of the virus. Many nations and their research laboratories across the world have been working day-night to find a vaccine to treat corona virus but nobody managed to develop a complete vaccine so ...

The latest figures in India of confirmed cases has reached 42,700 with close to 23,500 being active and 1400 deceased. The Indian Council of Medical Research (ICMR) had advised the states to use antibody testing for rounding up the positive cases in tackling the COVID-19 fight in India. But over time it has been substantiated ...